Igenica Header
  | | | | |

 

Igenica Management
David V. Goeddel, Ph.D.
Executive Chairman
John K. Celebi, MBA Chief Business Officer
Guoqing Chen, Ph.D. VP of Research
Paul W. Sauer, MBA VP of Process Development
Igenica Management
David V. Goeddel, Ph.D.
Executive Chairman
John D. Diekman, Ph.D.
Carl L. Gordon, Ph.D., CFA
Robert Schreiber, Ph.D.
Igenica Management
Robert Schreiber, Ph.D.
Chairman
Rudolf Aebersold, Ph.D.  
Frederick Appelbaum, M.D.  
Thomas Kipps, M.D., Ph.D.  
Richard Klausner, M.D.  
Jeffrey V. Ravetch, M.D., Ph.D.  
Richard Ulevitch, Ph.D.  
Emil Unanue, M.D.  
 
 
 
 
Igenica Leadership

Dr. Gordon is a founding General Partner of OrbiMed and Co-Head of Private Equity. Dr. Gordon is active in both private equity and small-capitalization public equity investments. He was a senior biotechnology analyst at Mehta and Isaly from 1995 to 1997. He was a Fellow at The Rockefeller University from 1993 to 1995. Dr. Gordon received a Ph.D. in Molecular Biology from the Massachusetts Institute of Technology. His doctoral work involved studies of protein folding and assembly. He received a Bachelors degree from Harvard College.